The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - PAREXEL (I)
Honoraria - PAREXEL (I)
Research Funding - AstraZeneca; Merck KGaA; Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
 
Honoraria - Synthon

A multicenter phase I trial of the DNA-dependent protein kinase (DNA-PK) inhibitor M3814 in patients with solid tumors.
 
Mark van Bussel
No Relationships to Disclose
 
Morten Mau-Soerensen
No Relationships to Disclose
 
Lars Damstrup
Employment - Merck KGaA
 
Dorte Nielsen
Employment - Novo Nordisk (I)
 
Henk M.W. Verheul
No Relationships to Disclose
 
Philippe Georges Aftimos
No Relationships to Disclose
 
Maja J. De Jonge
No Relationships to Disclose
 
Karin Berghoff
Employment - CSL Behring (I); Merck KGaA
Stock and Other Ownership Interests - CSL Behring (I)
 
Jan H.M. Schellens
No Relationships to Disclose